Inflammation and cancer: How hot is the link?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aggarwal, 2004, Nuclear factor-kappaB: the enemy within, Cancer Cell, 6, 203, 10.1016/j.ccr.2004.09.003
Martey, 2004, Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer, Am J Physiol Lung Cell Mol Physiol, 287, L981, 10.1152/ajplung.00239.2003
Castle, 2001, An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV), Cancer Epidemiol Biomarkers Prev, 10, 1021
Di Bisceglie, 1997, Hepatitis C and hepatocellular carcinoma, Hepatology, 26, 34S, 10.1002/hep.510260706
Kanoh, 2001, Significance of contracted cholecystitis lesions as high risk for gallbladder carcinogenesis, Cancer Lett, 169, 7, 10.1016/S0304-3835(01)00523-7
Offersen, 2002, Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis, Br J Cancer, 87, 1422, 10.1038/sj.bjc.6600615
Garcea, 2005, Role of inflammation in pancreatic carcinogenesis and the implications for future therapy, Pancreatology, 5, 514, 10.1159/000087493
Murphy, 2005, Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study, World J Gastroenterol, 11, 7290, 10.3748/wjg.v11.i46.7290
Mossman, 1996, Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers, Cancer Invest, 14, 466, 10.3109/07357909609018904
Okano, 2001, From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases, Pediatr Hematol Oncol, 18, 427, 10.1080/088800101750476014
Vagefi, 2005, Colorectal cancer in patients with inflammatory bowel disease, Clin Colorectal Cancer, 4, 313, 10.3816/CCC.2005.n.003
Berwick, 2005, Sun exposure and mortality from melanoma, J Natl Cancer Inst, 97, 195, 10.1093/jnci/dji019
Nelson, 2004, The role of inflammation in the pathogenesis of prostate cancer, J Urol, 172, S6, 10.1097/01.ju.0000142058.99614.ff
Aggarwal, 2003, Signalling pathways of the TNF superfamily: a double-edged sword, Nat Rev Immunol, 3, 745, 10.1038/nri1184
Balkwill, 2002, Tumor necrosis factor or tumor promoting factor?, Cytokine Growth Factor Rev, 13, 135, 10.1016/S1359-6101(01)00020-X
Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0
Komori, 1993, Tumor necrosis factor acts as a tumor promoter in BALB/3T3 cell transformation, Cancer Res, 53, 1982
Digel, 1989, Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia, Blood, 73, 1242, 10.1182/blood.V73.5.1242.1242
Digel, 1990, Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo, Blood, 76, 1607, 10.1182/blood.V76.8.1607.1607
Giri, 1998, Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates, J Biol Chem, 273, 14008, 10.1074/jbc.273.22.14008
Liu, 1998, The role of type I and type II tumor necrosis factor (TNF) receptors in the ability of TNF-alpha to transduce a proliferative signal in the human megakaryoblastic leukemic cell line Mo7e, Cancer Res, 58, 2217
Tsukasaki, 2001, Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers, Cancer Res, 61, 3770
Stifter, 2005, Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis, Eur J Haematol, 75, 485, 10.1111/j.1600-0609.2005.00551.x
Duncombe, 1989, Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia, J Immunol, 143, 3828, 10.4049/jimmunol.143.11.3828
Elbaz, 1994, Tumor necrosis factor and human acute leukemia, Leuk Lymphoma, 12, 191, 10.3109/10428199409059589
Montesano, 2005, Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells, J Cell Sci, 118, 3487, 10.1242/jcs.02467
Kalthoff, 1993, Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha, Proc Natl Acad Sci USA, 90, 8972, 10.1073/pnas.90.19.8972
Schmiegel, 1993, Tumor necrosis factor alpha induces the expression of transforming growth factor alpha and the epidermal growth factor receptor in human pancreatic cancer cells, Proc Natl Acad Sci USA, 90, 863, 10.1073/pnas.90.3.863
Wu, 1993, Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression, Cancer Res, 53, 1939
Takeyama, 1991, Tumor necrosis factor expression by human ovarian carcinoma in vivo, Cancer Res, 51, 4476
Naylor, 1993, Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression, J Clin Invest, 91, 2194, 10.1172/JCI116446
Woodworth, 1995, Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells, Proc Natl Acad Sci USA, 92, 2840, 10.1073/pnas.92.7.2840
Aggarwal, 1996, Triple helix-forming oligodeoxyribonucleotides targeted to the human tumor necrosis factor (TNF) gene inhibit TNF production and block the TNF-dependent growth of human glioblastoma tumor cells, Cancer Res, 56, 5156
Goillot, 1992, Tumor necrosis factor as an autocrine growth factor for neuroblastoma, Cancer Res, 52, 3194
Foa, 1990, Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease, Blood, 76, 393, 10.1182/blood.V76.2.393.bloodjournal762393
Nabors, 2003, Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR, Cancer Res, 63, 4181
Rosen, 1991, Tumor necrosis factor stimulates epithelial tumor cell motility, Cancer Res, 51, 5315
Yoshida, 1997, Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis, Mol Cell Biol, 17, 4015, 10.1128/MCB.17.7.4015
Leibovich, 1987, Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha, Nature, 329, 630, 10.1038/329630a0
Lind, 2004, Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition, Proc Natl Acad Sci USA, 101, 4972, 10.1073/pnas.0307106101
Kitakata, 2002, Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells, Cancer Res, 62, 6682
Arnott, 2004, Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development, Oncogene, 23, 1902, 10.1038/sj.onc.1207317
Knight, 2000, Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice, J Exp Med, 192, 1809, 10.1084/jem.192.12.1809
Korner, 2000, Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype, J Exp Med, 191, 89, 10.1084/jem.191.1.89
Pikarsky, 2004, NF-kappaB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924
Orosz, 1993, Enhancement of experimental metastasis by tumor necrosis factor, J Exp Med, 177, 1391, 10.1084/jem.177.5.1391
Vanhamme, 1993, Tumor necrosis factor alpha and interleukin 1 alpha induce anchorage independence in v-jun transgenic murine cells, Cancer Res, 53, 615
Arlt, 2002, Autocrine production of interleukin 1beta confers constitutive nuclear factor kappaB activity and chemoresistance in pancreatic carcinoma cell lines, Cancer Res, 62, 910
Saijo, 2002, Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction, J Immunol, 169, 469, 10.4049/jimmunol.169.1.469
Klein, 1989, Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6, Blood, 73, 517, 10.1182/blood.V73.2.517.517
Voorzanger, 1996, Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors, Cancer Res, 56, 5499
Okamoto, 1995, Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin 6, Cancer Res, 55, 4581
Landi, 2003, Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer, Cancer Res, 63, 3560
Angelo, 2002, Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53, Cancer Res, 62, 932
Luca, 1997, Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis, Am J Pathol, 151, 1105
Huang, 2002, Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma, Am J Pathol, 161, 125, 10.1016/S0002-9440(10)64164-8
Xu, 2000, Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells, Cancer Res, 60, 4610
Van Meir, 1992, Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system, Cancer Res, 52, 4297
Savage, 2004, Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma, Cancer Epidemiol Biomarkers Prev, 13, 2251, 10.1158/1055-9965.2251.13.12
Sparmann, 2004, Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis, Cancer Cell, 6, 447, 10.1016/j.ccr.2004.09.028
Kothapalli, 2005, Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukaemia, Int J Oncol, 26, 529
Charo, 2006, The many roles of chemokines and chemokine receptors in inflammation, N Engl J Med, 354, 610, 10.1056/NEJMra052723
Kulbe, 2004, The chemokine network in cancer—much more than directing cell movement, Int J Dev Biol, 48, 489, 10.1387/ijdb.041814hk
Muller, 2001, Involvement of chemokine receptors in breast cancer metastasis, Nature, 410, 50, 10.1038/35065016
Wang, 2001, Nuclear factor-kappa B activation by the CXC chemokine melanoma growth-stimulatory activity/growth-regulated protein involves the MEKK1/p38 mitogen-activated protein kinase pathway, J Biol Chem, 276, 3650, 10.1074/jbc.M006115200
Scotton, 2001, Epithelial cancer cell migration: a role for chemokine receptors?, Cancer Res, 61, 4961
Scotton, 2002, Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer, Cancer Res, 62, 5930
Porcile, 2004, CXCR4 activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line, Ann N Y Acad Sci, 1030, 162, 10.1196/annals.1329.021
Johrer, 2005, Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma, Clin Cancer Res, 11, 2459, 10.1158/1078-0432.CCR-04-0405
Kimsey, 2004, Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion, Cancer J, 10, 374, 10.1097/00130404-200411000-00007
Schwarze, 2005, Modulation of CXCL14 (BRAK) expression in prostate cancer, Prostate, 64, 67, 10.1002/pros.20215
Sano, 1995, Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res, 55, 3785
Tsujii, 1997, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential, Proc Natl Acad Sci USA, 94, 3336, 10.1073/pnas.94.7.3336
Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705, 10.1016/S0092-8674(00)81433-6
Takeda, 2003, Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis, Cancer Res, 63, 4872
Einspahr, 2003, Association between Cyclooxygenase expression and colorectal adenoma characteristics, Cancer Res, 63, 3891
Liu, 2003, Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways, Cancer Res, 63, 3632
Sun, 2002, Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells, Cancer Res, 62, 6323
Tang, 2002, Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells, Cancer Res, 62, 4903
Half, 2002, Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ, Cancer Res, 62, 1676
Kundu, 2002, Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer, Cancer Res, 62, 2343
Wolff, 1998, Expression of cyclooxygenase-2 in human lung carcinoma, Cancer Res, 58, 4997
Pold, 2004, Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer, Cancer Res, 64, 1853, 10.1158/0008-5472.CAN-03-3262
Chan, 1999, Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck, Cancer Res, 59, 991
Sales, 2002, Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1, Cancer Res, 62, 424
Klimp, 2001, Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages, Cancer Res, 61, 7305
Shono, 2001, Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations, Cancer Res, 61, 4375
Subbarayan, 2001, Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells, Cancer Res, 61, 2720
Denkert, 2001, Expression of cyclooxygenase 2 in human malignant melanoma, Cancer Res, 61, 303
Goulet, 2003, Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression, Cancer Biol Ther, 2, 713, 10.4161/cbt.2.6.627
Souza, 2000, Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells, Cancer Res, 60, 5767
Zimmermann, 1999, Cyclooxygenase-2 expression in human esophageal carcinoma, Cancer Res, 59, 198
von Rahden, 2005, Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma, Cancer Res, 65, 5038, 10.1158/0008-5472.CAN-04-1107
Tucker, 1999, Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer, Cancer Res, 59, 987
Ristimaki, 1997, Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res, 57, 1276
Mohammed, 1999, Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder, Cancer Res, 59, 5647
Boado, 1992, Differential expression of arachidonate 5-lipoxygenase transcripts in human brain tumors: evidence for the expression of a multitranscript family, Proc Natl Acad Sci USA, 89, 9044, 10.1073/pnas.89.19.9044
Ye, 2005, Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke, Carcinogenesis, 26, 827, 10.1093/carcin/bgi012
Ye, 2004, Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking, Toxicology, 203, 179, 10.1016/j.tox.2004.06.004
Kelavkar, 2001, Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis, Carcinogenesis, 22, 1765, 10.1093/carcin/22.11.1765
Rioux, 1998, Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents, Carcinogenesis, 19, 1393, 10.1093/carcin/19.8.1393
Jiang, 1994, Inhibition of two-stage skin carcinogenesis as well as complete skin carcinogenesis by oral administration of TMK688, a potent lipoxygenase inhibitor, Carcinogenesis, 15, 807, 10.1093/carcin/15.5.807
Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 161, 10.1038/nrc745
Coussens, 2000, MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis, Cell, 103, 481, 10.1016/S0092-8674(00)00139-2
van’t Veer, 2002, Gene expression profiling predicts clinical outcome of breast cancer, Nature, 415, 530, 10.1038/415530a
Minn, 2005, Genes that mediate breast cancer metastasis to lung, Nature, 436, 518, 10.1038/nature03799
Ii, 2006, Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis, Exp Biol Med (Maywood), 231, 20, 10.1177/153537020623100103
Hellwig-Burgel, 2005, Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions, J Interferon Cytokine Res, 25, 297, 10.1089/jir.2005.25.297
Metzen, 2004, HIF hydroxylation and cellular oxygen sensing, Biol Chem, 385, 223
Bilton, 2003, The subtle side to hypoxia inducible factor (HIFalpha) regulation, Eur J Biochem, 270, 791, 10.1046/j.1432-1033.2003.03446.x
Hellwig-Burgel, 1999, Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1, Blood, 94, 1561, 10.1182/blood.V94.5.1561
Bogdan, 2001, Nitric oxide and the regulation of gene expression, Trends Cell Biol, 11, 66, 10.1016/S0962-8924(00)01900-0
Nathan, 1992, Nitric oxide as a secretory product of mammalian cells, FASEB J, 6, 3051, 10.1096/fasebj.6.12.1381691
Geller, 1998, Molecular biology of nitric oxide synthases, Cancer Metastasis Rev, 17, 7, 10.1023/A:1005940202801
Lirk, 2002, Inducible nitric oxide synthase—time for reappraisal, Curr Drug Targets Inflamm Allergy, 1, 89, 10.2174/1568010023344913
Closa, 2004, Oxygen free radicals and the systemic inflammatory response, IUBMB Life, 56, 185, 10.1080/15216540410001701642
Schraufstatter, 1988, Oxidant-induced DNA damage of target cells, J Clin Invest, 82, 1040, 10.1172/JCI113660
Aggarwal, 2006, Molecular targets of dietary agents for prevention and therapy of cancer, Biochem Pharmacol, 71, 1397, 10.1016/j.bcp.2006.02.009
Dreyer, 1992, Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors, Cell, 68, 879, 10.1016/0092-8674(92)90031-7
Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma, Proc Natl Acad Sci USA, 94, 4318, 10.1073/pnas.94.9.4318
Clark, 2002, The role of PPARs in inflammation and immunity, J Leukoc Biol, 71, 388, 10.1189/jlb.71.3.388
Daynes, 2002, Emerging roles of PPARs in inflammation and immunity, Nat Rev Immunol, 2, 748, 10.1038/nri912
Chawla, 2001, PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation, Nat Med, 7, 48, 10.1038/83336
Grommes, 2004, Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists, Lancet Oncol, 5, 419, 10.1016/S1470-2045(04)01509-8
Sarraf, 1999, Loss-of-function mutations in PPAR gamma associated with human colon cancer, Mol Cell, 3, 799, 10.1016/S1097-2765(01)80012-5
Shishodia, 2004, Nuclear factor-kappaB: a friend or a foe in cancer?, Biochem Pharmacol, 68, 1071, 10.1016/j.bcp.2004.04.026
Greten, 2004, IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer, Cell, 118, 285, 10.1016/j.cell.2004.07.013
Maeda, 2005, IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014
Hagemann, 2005, Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK, J Immunol, 175, 1197, 10.4049/jimmunol.175.2.1197
Anto, 2002, Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2, Carcinogenesis, 23, 1511, 10.1093/carcin/23.9.1511
Thornburg, 2003, Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma, Cancer Res, 63, 8293
Yang, 2001, Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells, Cancer Res, 61, 4901
Dhawan, 2002, Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression, Cancer Res, 62, 7335
Dong, 1999, The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma, Cancer Res, 59, 3495
Varro, 2004, Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis, Cancer Res, 64, 1695, 10.1158/0008-5472.CAN-03-2399
Suganuma, 2001, Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori, Cancer Res, 61, 6356
Maggio-Price, 2006, Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice, Cancer Res, 66, 828, 10.1158/0008-5472.CAN-05-2448
Brandt, 2005, NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein, Proc Natl Acad Sci USA, 102, 9300, 10.1073/pnas.0409873102
Ludwig, 2001, Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation, Cancer Res, 61, 4526
O’Connell, 1995, Cellular proliferation and activation of NF kappa B are induced by autocrine production of tumor necrosis factor alpha in the human T lymphoma line HuT 78, J Biol Chem, 270, 7399, 10.1074/jbc.270.13.7399
Cicek, 2005, Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity, Cancer Res, 65, 3586, 10.1158/0008-5472.CAN-04-3139
Abdel-Mageed, 1998, Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response, Cancer Res, 58, 2335
Biswas, 2004, NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis, Proc Natl Acad Sci USA, 101, 10137, 10.1073/pnas.0403621101
Otsuka, 1999, Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells, Cancer Res, 59, 4446
Duffey, 1999, Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo, Cancer Res, 59, 3468
Wang, 1999, Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB, Nat Med, 5, 412, 10.1038/7410
Gordon, 2005, Nuclear factor-kappaB-dependent mechanisms in breast cancer cells regulate tumor burden and osteolysis in bone, Cancer Res, 65, 3209, 10.1158/0008-5472.CAN-04-4017
Dong, 2001, Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma, Cancer Res, 61, 5911
Loercher, 2004, Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma, Cancer Res, 64, 6511, 10.1158/0008-5472.CAN-04-0852
Andela, 2000, Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB, Cancer Res, 60, 6557
Helbig, 2003, NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4, J Biol Chem, 278, 21631, 10.1074/jbc.M300609200
Huang, 2000, Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8, Cancer Res, 60, 5334
Kawai, 1999, Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes, Cancer Res, 59, 6038
Konturek, 2004, Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors, Dig Dis Sci, 49, 1075, 10.1023/B:DDAS.0000037790.11724.70
Geborek, 2005, Population based studies of biological antirheumatic drug use in southern Sweden: comparison with pharmaceutical sales, Ann Rheum Dis, 64, 1805, 10.1136/ard.2005.036715
Seitz, 1998, Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB, Proc Natl Acad Sci USA, 95, 2307, 10.1073/pnas.95.5.2307
Gapuzan, 2002, Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kappaB have a malignantly transformed phenotype, Oncogene, 21, 2484, 10.1038/sj.onc.1205333
Dajee, 2003, NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia, Nature, 421, 639, 10.1038/nature01283
van Hogerlinden, 1999, Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling, Cancer Res, 59, 3299
Ricca, 2001, relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells, Br J Cancer, 85, 1914, 10.1054/bjoc.2001.2174
Ryan, 2000, Role of NF-kappaB in p53-mediated programmed cell death, Nature, 404, 892, 10.1038/35009130
Rocha, 2003, p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor, Mol Cell, 12, 15, 10.1016/S1097-2765(03)00223-5
Tergaonkar, 2002, p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy, Cancer Cell, 1, 493, 10.1016/S1535-6108(02)00068-5
Hellin, 1998, Nuclear factor-kappaB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug, Oncogene, 16, 1187, 10.1038/sj.onc.1201638
Aggarwal, 2000, Tumor necrosis factors: a double-edged sword, J Clin Ligand Assay, 23, 181
Gaur, 2003, Regulation of proliferation, survival and apoptosis by members of the TNF superfamily, Biochem Pharmacol, 66, 1403, 10.1016/S0006-2952(03)00490-8
Aggarwal, 2006, From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer, Exp Opin Ther Targets, 10, 87, 10.1517/14728222.10.1.87
Estrov, 1993, Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia, Leuk Lymphoma, 10, 407, 10.3109/10428199309148197
Trentin, 1994, Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia, Blood, 84, 4249, 10.1182/blood.V84.12.4249.bloodjournal84124249
Reittie, 1996, Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia, Leuk Lymphoma, 22, 83, 10.3109/10428199609051732
Cordingley, 1988, Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies, Lancet, 1, 969, 10.1016/S0140-6736(88)91782-5
Freedman, 1992, Evidence for voltage modulation of IL-2 production in mitogen-stimulated human peripheral blood lymphocytes, J Immunol, 149, 3784, 10.4049/jimmunol.149.12.3784
Takeda, 1986, Identity of differentiation inducing factor and tumour necrosis factor, Nature, 323, 338, 10.1038/323338a0
Williamson, 1983, Human tumor necrosis factor produced by human B-cell lines: synergistic cytotoxic interaction with human interferon, Proc Natl Acad Sci USA, 80, 5397, 10.1073/pnas.80.17.5397
Shishodia, 2005, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma, Biochem Pharmacol, 70, 700, 10.1016/j.bcp.2005.04.043
Aggarwal, 1996, Tumor necrosis factors: developments during the last decade, Eur Cytokine Netw, 7, 93
Lilli, 2002, Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene, Int J Cancer, 98, 824, 10.1002/ijc.10306
Sugarman, 1985, Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro, Science, 230, 943, 10.1126/science.3933111
Selmaj, 1990, Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor, J Immunol, 144, 129, 10.4049/jimmunol.144.1.129
Ranges, 1988, Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines, J Exp Med, 167, 1472, 10.1084/jem.167.4.1472
Schiller, 1992, Tumor necrosis factor, but not other hematopoietic growth factors, prolongs the survival of hairy cell leukemia cells, Leuk Res, 16, 337, 10.1016/0145-2126(92)90135-T
Trentin, 1991, Tumor necrosis factor-alpha and B-cell growth factor induce leukemic hairy cells to proliferate in vitro, Cancer Detect Prev, 15, 385
Jablonska, 2005, TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL), Leuk Lymphoma, 46, 1307, 10.1080/10428190500158789
Rieckmann, 1991, IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function, J Immunol, 146, 3462, 10.4049/jimmunol.146.10.3462
Miura, 1992, Stimulatory effect of tumor necrosis factor-alpha on the growth of CMK, a human megakaryoblastic leukemia cell line, Leuk Res, 16, 281, 10.1016/0145-2126(92)90066-G
Hoang, 1989, Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor, J Exp Med, 170, 15, 10.1084/jem.170.1.15
Murohashi, 1993, Growth potentiating activity of endogenous production of interleukin-1 and tumor necrosis factor alpha in blast cells of acute myeloblastic leukemia, Exp Hematol, 21, 846
Takada, 2005, Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells, Blood, 106, 641, 10.1182/blood-2004-12-4589
Campioni, 2005, Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes, Am J Pathol, 166, 557, 10.1016/S0002-9440(10)62277-8
Okada, 2005, Effects of interferon-beta on the cytokine production of astrocytes, J Neuroimmunol, 159, 48, 10.1016/j.jneuroim.2004.09.013
Niu, 2004, Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells, J Biol Chem, 279, 16452, 10.1074/jbc.M309789200
Jung, 2003, IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, FASEB J, 17, 2115, 10.1096/fj.03-0329fje
McCarron, 2002, Influence of cytokine gene polymorphisms on the development of prostate cancer, Cancer Res, 62, 3369
Xu, 2001, B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses, Mol Cell Biol, 21, 4067, 10.1128/MCB.21.12.4067-4074.2001
Vidal-Vanaclocha, 2000, IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1, Proc Natl Acad Sci USA, 97, 734, 10.1073/pnas.97.2.734
Chang, 2005, The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia, Cancer Res, 65, 4496, 10.1158/0008-5472.CAN-05-0129
Gupta, 2003, Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer, Cancer Res, 63, 906
Zweifel, 2002, Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors, Cancer Res, 62, 6706